We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT05268666
Brief Title: A Study of Orally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid Tumors

First Submitted : February 11, 2022
First Submitted that Met QC Criteria : February 24, 2022
First Posted : March 7, 2022

Last Update Submitted that Met QC Criteria : August 19, 2022
Last Update Posted : August 22, 2022